Am. J. Respir. Crit. Care Med., Volume 159, Number 1, January 1999, 37-42

Intrapleural Urokinase versus Normal Saline in the Treatment of Complicated Parapneumonic Effusions and Empyema
A Randomized, Double-Blind Study

DEMOSTHENES BOUROS, SOPHIA SCHIZA, NIKOLAOS TZANAKIS, GEORGE CHALKIADAKIS, JOHN DROSITIS, and NIKOLAOS SIAFAKAS

Departments of Thoracic Medicine, Thoracic Surgery, and Clinical Pharmacology, Medical School, University of Crete, and University General Hospital, Heraklion, Crete, Greece

Intrapleural administration of fibrinolytic agents has been shown to be effective and safe in the treatment of loculated parapneumonic pleural effusions. However, controlled studies of the possible role of the activity of urokinase (UK) through the volume effect are lacking. We therefore investigated the hypothesis that UK is effective through the lysis of pleural adhesions and not through the volume effect. Thirty-one consecutive patients with multiloculated pleural effusions were randomly assigned to receive either intrapleural UK (15 patients) or normal saline (NS) (16 patients) for 3 d, in a double-blind manner. All patients had inadequate drainage through a chest tube (< 70 ml/24 h). UK was given daily through the chest tube in a dose of 100.000 IU diluted in 100 ml of NS. Controls were given the same volume of NS intrapleurally. Response was assessed by clinical outcome, fluid drainage, chest radiography, pleural ultrasonography (US) and/or computed tomography (CT). Clinical and radiographic improvement was noted in all but two patients in the UK group but in only four in the control group. The net mean volume drained during the 3-d treatment period was significantly greater in the UK group (970 ± 75 ml versus 280 ± 55 ml, p < 0.001). Pleural fluid drainage was complete in 13 (86.5%) patients in the UK group (two patients were treated through video-assisted thoracoscopy) but in only four (25%) in the control group. Twelve patients in the control group were subsequently treated with UK and six of them had complete drainage; the remaining six patients had complete drainage after video-assisted thoracoscopy. Our results suggest that UK is effective in the treatment of loculated pleural effusions through the lysis of pleural adhesions and not through the volume effect.

This article has been cited by other articles:

				C-L. Chung, C-H. Chen, C-Y. Yeh, J-R. Sheu, and S-C. Chang Early effective drainage in the treatment of loculated tuberculous pleurisy Eur. Respir. J., June 1, 2008; 31(6): 1261 - 1267. [Abstract] [Full Text] [PDF]

				D. A. Gervais, D. A. Levis, P. F. Hahn, R. N. Uppot, R. S. Arellano, and P. R. Mueller Adjunctive Intrapleural Tissue Plasminogen Activator Administered via Chest Tubes Placed with Imaging Guidance: Effectiveness and Risk for Hemorrhage Radiology, March 1, 2008; 246(3): 956 - 963. [Abstract] [Full Text] [PDF]

				C.-H. Chen, W.-H. Hsu, H.-J. Chen, W. Chen, C.-M. Shih, T.-C. Hsia, and C.-Y. Tu Different Bacteriology and Prognosis of Thoracic Empyemas Between Patients With Chronic and End-Stage Renal Disease Chest, August 1, 2007; 132(2): 532 - 539. [Abstract] [Full Text] [PDF]

				J. E. Heffner Update in pulmonary medicine. Ann Intern Med, November 21, 2006; 145(10): 765 - 773. [Full Text] [PDF]

				G. F. Tassi, R. J. O. Davies, and M. Noppen Advanced techniques in medical thoracoscopy. Eur. Respir. J., November 1, 2006; 28(5): 1051 - 1059. [Abstract] [Full Text] [PDF]

				N. Maskell, A. Nunn, and R. J O Davies Intrapleural streptokinase for pleural infection. BMJ, March 4, 2006; 332(7540): 552 - 552. [Full Text]

				Managing empyema in adults DTB, March 1, 2006; 44(3): 17 - 21. [Abstract] [Full Text] [PDF]

				Y. Tokuda, D. Matsushima, G. H. Stein, and S. Miyagi Intrapleural Fibrinolytic Agents for Empyema and Complicated Parapneumonic Effusions: A Meta-analysis Chest, March 1, 2006; 129(3): 783 - 790. [Abstract] [Full Text] [PDF]

				D. Bouros, K. M Antoniou, and R. W Light Intrapleural streptokinase for pleural infection BMJ, January 21, 2006; 332(7534): 133 - 134. [Full Text] [PDF]

				R. W. Light Parapneumonic effusions and empyema. Proceedings of the ATS, January 1, 2006; 3(1): 75 - 80. [Abstract] [Full Text] [PDF]

				M. H. Brutsche, G.-F. Tassi, S. Gyorik, M. Gokcimen, C. Renard, G. P. Marchetti, and J.-M. Tschopp Treatment of Sonographically Stratified Multiloculated Thoracic Empyema by Medical Thoracoscopy Chest, November 1, 2005; 128(5): 3303 - 3309. [Abstract] [Full Text] [PDF]

				A Medford and N Maskell Pleural effusion Postgrad. Med. J., November 1, 2005; 81(961): 702 - 710. [Abstract] [Full Text] [PDF]

				P. Misthos, E. Sepsas, M. Konstantinou, K. Athanassiadi, I. Skottis, and A. Lioulias Early use of intrapleural fibrinolytics in the management of postpneumonic empyema. A prospective study Eur. J. Cardiothorac. Surg., October 1, 2005; 28(4): 599 - 603. [Abstract] [Full Text] [PDF]

				C.-L. Chung, C.-H. Chen, J.-R. Sheu, Y.-C. Chen, and S.-C. Chang Proinflammatory Cytokines, Transforming Growth Factor-{beta}1, and Fibrinolytic Enzymes in Loculated and Free-Flowing Pleural Exudates Chest, August 1, 2005; 128(2): 690 - 697. [Abstract] [Full Text] [PDF]

				N. A. Maskell, C. W.H. Davies, A. J. Nunn, E. L. Hedley, F. V. Gleeson, R. Miller, R. Gabe, G. L. Rees, T. E.A. Peto, M. A. Woodhead, et al. U.K. Controlled Trial of Intrapleural Streptokinase for Pleural Infection N. Engl. J. Med., March 3, 2005; 352(9): 865 - 874. [Abstract] [Full Text] [PDF]

				Y. C. G. Lee Ongoing Search for Effective Intrapleural Therapy for Empyema: Is Streptokinase the Answer? Am. J. Respir. Crit. Care Med., July 1, 2004; 170(1): 1 - 2. [Full Text] [PDF]

				A. H. Diacon, J. Theron, M. M. Schuurmans, B. W. Van de Wal, and C. T. Bolliger Intrapleural Streptokinase for Empyema and Complicated Parapneumonic Effusions Am. J. Respir. Crit. Care Med., July 1, 2004; 170(1): 49 - 53. [Abstract] [Full Text] [PDF]

				M. Weinstein, R. Restrepo, P. G. Chait, B. Connolly, M. Temple, and C. Macarthur Effectiveness and Safety of Tissue Plasminogen Activator in the Management of Complicated Parapneumonic Effusions Pediatrics, March 1, 2004; 113(3): e182 - 185. [Abstract] [Full Text] [PDF]

				O. Michel Role of lipopolysaccharide (LPS) in asthma and other pulmonary conditions Innate Immunity, October 1, 2003; 9(5): 293 - 300. [Abstract] [PDF]

				R. G. Wells and P. L. Havens Intrapleural Fibrinolysis for Parapneumonic Effusion and Empyema in Children Radiology, August 1, 2003; 228(2): 370 - 378. [Abstract] [Full Text] [PDF]

				C W H Davies, F V Gleeson, and R J O Davies BTS guidelines for the management of pleural infection Thorax, May 1, 2003; 58(90002): ii18 - 28. [Full Text]

				C. A Walker, M. B. Shirk, M. M Tschampel, and J. A Visconti Intrapleural Alteplase in a Patient with Complicated Pleural Effusion Ann. Pharmacother., March 1, 2003; 37(3): 376 - 379. [Abstract] [Full Text] [PDF]

				G. Cohen, V. Hjortdal, M. Ricci, A. Jaffe, C. Wallis, R. Dinwiddie, M. J. Elliott, and M. R. de Leval Primary thoracoscopic treatment of empyema in children J. Thorac. Cardiovasc. Surg., January 1, 2003; 125(1): 79 - 84. [Abstract] [Full Text] [PDF]

				A H Thomson, J Hull, M R Kumar, C Wallis, and I M Balfour Lynn Randomised trial of intrapleural urokinase in the treatment of childhood empyema Thorax, April 1, 2002; 57(4): 343 - 347. [Abstract] [Full Text] [PDF]

				G. L. Colice, A. Curtis, J. Deslauriers, J. Heffner, R. Light, B. Littenberg, S. Sahn, R. A. Weinstein, and R. D. Yusen Medical and Surgical Treatment of Parapneumonic Effusions : An Evidence-Based Guideline Chest, October 1, 2000; 118(4): 1158 - 1171. [Abstract] [Full Text] [PDF]

				C. W. H. DAVIES, S. E. KEARNEY, F. V. GLEESON, and R. J. O. DAVIES Predictors of Outcome and Long-term Survival in Patients with Pleural Infection Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1682 - 1687. [Abstract] [Full Text]

				T. K. Lim and A. P. C. Yim Management of Pleural Empyema Chest, September 1, 1999; 116(3): 845 - 846. [Full Text] [PDF]